A carregar...

Monoclonal antibody therapy in Langerhans cell histiocytosis--feasible and reasonable?

Many recent studies have demonstrated the range of disorders in which monoclonal antibodies have a clinical role. The monoclonal antibody NA1/34, directed against a surface antigen present on lesional cells ('LCH cells'), has been found to localise in vivo to sites of disease. This review...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kelly, K. M., Pritchard, J.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1994
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2149709/
https://ncbi.nlm.nih.gov/pubmed/8075008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!